Early response of bone metastases can predict tumor response in patients with non‑small‑cell lung cancer with bone metastases in the treatment with nivolumab-Reference-Cited by-同舟云学术

Early response of bone metastases can predict tumor response in patients with non‑small‑cell lung cancer with bone metastases in the treatment with nivolumab

Published:2020-07-10 Issue:3 Volume:20 Page:2977-2986
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Nakata Eiji¹,Sugihara Shinsuke²,Sugawara Yoshifumi³,Kozuki Toshiyuki⁴,Harada Daijiro⁴,Nogami Naoyuki⁴,Nakahara Ryuichi¹,Furumatsu Takayuki¹,Tetsunaga Tomonori¹,Kunisada Toshiyuki¹,Ozaki Toshifumi¹

Affiliation:

1. Department of Orthopedic Surgery, Okayama University Hospital, Okayama 700‑8558, Japan

2. Department of Orthopedic Surgery, Shikoku Cancer Center, Matsuyama, Ehime 791‑0280, Japan

3. Department of Radiology, Shikoku Cancer Center, Matsuyama, Ehime 791‑0280, Japan

4. Department of Thoracic Oncology and Medicine, Shikoku Cancer Center, Matsuyama, Ehime 791‑0280, Japan

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of immune checkpoint inhibitor therapy on bone metastases in non-small-cell lung cancer;Frontiers in Immunology;2024-06-18

2. Response rate specific to bone metastasis of various cancers for immune checkpoint inhibitors: a systematic review;European Journal of Orthopaedic Surgery & Traumatology;2024-06-05

3. CT Hounsfield Unit value as a Treatment Response Indicator for Spinal Metastatic Lesions in Patients with Non-Small-Cell Lung Cancer;2024-02-28

4. Immunotherapy targeting PD‑1/PD‑L1: A potential approach for the treatment of cancer bone metastases (Review);International Journal of Oncology;2024-02-13

5. Novel predictors of immune checkpoint inhibitor response and prognosis in advanced non‐small‐cell lung cancer with bone metastasis;Cancer Medicine;2023-04-19